12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·11/05/2026 17:05:32
Listen to the news
Gainers
- Lakewood-Amedex (NASDAQ:LABT) shares moved upwards by 237.6% to $0.65 during Thursday's regular session.
- ADMA Biologics (NASDAQ:ADMA) stock increased by 25.62% to $13.16. The market value of their outstanding shares is at $2.3 billion. As per the news, the Q3 earnings report came out yesterday.
- Xeris Biopharma Holdings (NASDAQ:XERS) stock increased by 22.17% to $12.78. The company's market cap stands at $1.9 billion. As per the news, the Q3 earnings report came out today.
- CareCloud (NASDAQ:CCLD) stock rose 19.57% to $2.15. The company's market cap stands at $76.4 million. As per the news, the Q3 earnings report came out today.
- Precision BioSciences (NASDAQ:DTIL) shares rose 18.1% to $9.59. The market value of their outstanding shares is at $224.1 million. The company's, Q3 earnings came out 2 days ago.
- Ardent Health (NYSE:ARDT) shares increased by 17.51% to $15.27. The market value of their outstanding shares is at $1.8 billion. As per the news, the Q3 earnings report came out yesterday.
Losers
- SANUWAVE Health (NASDAQ:SNWV) stock fell 63.2% to $2.11 during Thursday's regular session. The company's market cap stands at $49.2 million.
- Veracyte (NASDAQ:VCYT) shares fell 54.48% to $23.91. The market value of their outstanding shares is at $4.1 billion. As per the press release, Q3 earnings came out yesterday.
- Annovis Bio (NYSE:ANVS) shares fell 42.15% to $0.7. The market value of their outstanding shares is at $51.6 million.
- Akebia Therapeutics (NASDAQ:AKBA) stock fell 35.11% to $0.45. The market value of their outstanding shares is at $192.5 million. The company's, Q3 earnings came out today.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock fell 35.05% to $0.15.
- Adagio Medical Holdings (NASDAQ:ADGM) shares fell 30.4% to $0.06. The market value of their outstanding shares is at $2.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.